Is Amyloid the Key? A Case Study of Donanemab in Alzheimer’s Disease

Authors

Shima O Ebed MD, Lehigh Valley Health NetworkFollow
Emily Zagorski Butler DO, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

2025

Published In/Presented At

Ebed, S. & Zagorski Butler, E. (2025). Is Amyloid the Key? A Case Study of Donanemab in Alzheimer’s Disease.

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine

Document Type

Poster